There are hints that the 10-year benefit seen in STICHES, the earlier trial, might be the result of inferior medical therapy.

Overall, though, the meta-analysis identified a reduction in ischemia—but not in hard outcomes—with early treatment.

MicroTransponder announced today that it raised $65 million in a Series F financing round to support its Vivistim system.

MicroTransponder has received $65m in Series F funds to enhance its stroke care offerings with the Vivistim Paired VNS System ...

The autopsy report from the NC Office of the Chief Medical Examiner concluded that Stuart C. Mast, 48, of Fleetwood, died ...

Cardiovascular disease is a general term that refers to many different types of heart problems. Heart disease is the No. 1 ...

Kicked off of Medicaid, Florida children with medically complex needs are offered a state insurance program designed for ...

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Kicked off of Medicaid, Florida children with medically complex needs are offered a state insurance program designed for ...

A woman who suffered a severe stroke while feeding her pet pug survived by sheer chance. Carole Clayton, 77, was hit with the ...

Shingles can also negatively affect blood sugar control, therefore diabetic patients who contract shingles have a higher risk of severe or prolonged complications ...

Up to 80% of first-time strokes are preventable, says the American Stroke Association. New guidelines offer a better look at ...